Emmanuelle Charpentier
for deciphering the molecular details of the type II bacterial immune system CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)-Cas and the creation of the CRISPR-Cas9 genome editing system, a truly revolutionary technique in genetic engineering, far more economical and faster than those previously available.